Concord Drugs Ltd share price logo

Concord Drugs Ltd

BSE: 538965

Small Cap

Pharma Sector

₹79.30

-0.17

(-0.21%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Concord Drugs shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-1%

Searches for Concord Drugs on INDmoney have decreased by 1% over the last 30 days.

Concord Drugs Stock Performance

as on September 16, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹76.80
    ₹79.85
    downward going graph

    3.15%

    Downside

    0.69%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹61.00
    ₹92.52
    downward going graph

    23.08%

    Downside

    16.67%

    Upside

    downward going graph

Concord Drugs share price movements today

Previous Close
₹79.47
Open
₹78.13
Volume
2,598.00
Upper Circuit
₹95.36
Lower Circuit
₹63.58
Day's Low - High
₹76.80 - ₹79.85
52 Week Low - High
₹61.00 - ₹92.52

Concord Drugs Historical Returns

1 Month Return
+ 12.88 %
3 Month Return
+ 0.25 %
1 Year Return
+ 13.64 %
3 Year Return
+ 135.05 %
5 Year Return
+ 197.64 %

Concord Drugs Fundamentals

as on September 16, 2026 at 4:01 pm IST

Market Cap

₹104.70 Cr

Return on Equity (ROE)

0.88

PE Ratio (TTM)

47.71

Return on capital employed (ROCE)

4.49

Industry PE ratio

51.81

Beta (LTM)

0.43

P/B Ratio

0.91

Dividend Yield

0

PEG Ratio

38.47

Quarterly Earnings Growth YOY

825

EPS (TTM)

0.34

Book Value

34.11

Concord Drugs Stock Valuation

as on September 16, 2026 at 4:01 pm IST

Concord Drugs in the last 5 years

  • Overview

  • Trends

Lowest (-961.50x)

January 3, 2025

Today (47.71x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (791.40x)

July 3, 2024

LowHigh

Today’s Price to Earnings Ratio: 47.71x

Concord Drugs Technical Analysis

Track how Concord Drugs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish12
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
0.45
Bullish
CCI (20)
29.55
Neutral
RSI (14)
99.99
Bearish
Momentum (10)
1.55
Neutral
ADI (14)
89.89
Bullish
Ultimate Oscillator (7,14,28)
84.57
Bullish

Moving Averages

Name

Value

Action

SMA (20)
78.37
Bullish
EMA (20)
78.59
Bullish
VWMA (20)
78.72
Bullish
SMA (50)
77.91
Bullish
EMA (50)
78.11
Bullish
SMA (200)
77.98
Bullish
EMA (200)
77.85
Bullish
KAMA (200)
79.29
Bullish
DEMA (200)
77.78
Bullish

Concord Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Concord Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Concord Drugs Ltd image
Concord Drugs Ltd
NA104.7039.53%0.70145
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Concord Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
7.52
12.78
15.64
11.69
12.36
10.8
10.39
13.61
10.28
16.97
37.89
20.94
Total Income
7.52
12.78
15.64
11.69
12.37
10.8
10.4
13.61
10.28
16.99
37.9
20.95
Expenses
5.91
12.15
15.29
10.86
11.49
9.41
9.35
12.59
9.18
16.05
36.4
18.66
Operating Profit
1.61
0.63
0.35
0.83
0.87
1.39
1.04
1.02
1.1
0.92
1.49
2.28
Operating Profit Margin %
21.41%
4.93%
2.24%
7.1%
7.04%
12.87%
10.01%
7.49%
10.7%
5.42%
3.93%
10.89%
Profit Before Interest, Tax and Depreciation
1.61
0.63
0.35
0.83
0.88
1.39
1.05
1.02
1.1
0.94
1.5
2.29
Interest
0.43
0.5
0.5
0.45
0.47
0.5
0.61
0.49
0.49
0.34
0.4
0.4
Depreciation
0.39
0.39
0.39
0.34
0.34
0.37
0.38
0.37
0.34
0.31
0.35
0.35
Profit Before Tax
0.79
-0.26
-0.54
0.04
0.07
0.52
0.06
0.16
0.27
0.29
0.75
1.54
Tax Paid
0.24
-0.01
-0.21
0.02
0.03
0.31
0.02
0.04
0.08
0.08
0.22
0.43
Profit After Tax
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.22
0.53
1.11
Total Net profit including share of profit / Loss from associate company
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.22
0.53
1.11
EPS
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
0.47
0.85
Actual EPS
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
0.47
0.85
Adjusted EPS
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
0.47
0.85
Diluted EPS
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
0.47
0.85

Concord Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
58.96
52.08
44.92
45.24
78.74
Total Income
59.06
52.09
44.93
45.26
78.77
Expenses
53.36
47.51
40.88
41.11
74.22
Operating Profit
5.6
4.57
4.04
4.13
4.52
Operating Profit Margin %
9.5%
8.77%
8.99%
9.13%
5.74%
Profit Before Interest, Tax and Depreciation
5.69
4.58
4.05
4.15
4.55
Interest
1.68
1.71
1.87
2.03
1.71
Depreciation
1.76
1.63
1.56
1.43
1.37
Profit Before Tax
2.25
1.24
0.62
0.69
1.47
Tax Paid
0.65
0.26
0.16
0.35
0.42
Profit After Tax
1.59
0.99
0.47
0.34
1.06
Total Net profit including share of profit / Loss from associate company
1.59
0.99
0.47
0.34
1.06
EPS
1.82
1.06
0.47
0.34
0.95
Actual EPS
1.82
1.06
0.47
0.34
0.95
Adjusted EPS
1.82
1.06
0.47
0.34
0.95
Diluted EPS
1.82
1.06
0.47
0.34
0.95

Concord Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.77
1.66
0.79
3.72
Cash Flow from Investing Activities
0.01
-1.41
0.01
0.01
Cash Flow from Financing Activities
1.68
0.62
0.27
-1.43
Net Cash Flow
0.01
0.02
0.07
-0.02

Concord Drugs Stock Shareholding Pattern

Numbers in percentages

Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Nov 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
55.41%
55.41%
55.41%
55.41%
54.39%
54.39%
54.39%
54.39%
54.39%
45.08%
54.39%
54.39%
45.08%
Public
44.59%
44.59%
44.59%
44.59%
45.61%
45.61%
45.61%
45.61%
45.61%
54.92%
45.61%
45.61%
54.92%
Total Outstanding Shares
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,31,75,000
1,00,00,000
1,00,00,000
1,31,75,000
Total Shareholders
3,963
4,032
4,734
4,755
5,073
5,073
5,252
5,189
4,718
4,597
4,597
4,464
4,435

Concord Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Concord Drugs.

  • Concord Drugs Ltd Earnings Results

    Concord Drugs Ltd’s net profit jumped 825% since last year same period to ₹1.11Cr in the Q1 2026-2027. On a quarterly growth basis, Concord Drugs Ltd has generated 109.43% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Concord Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, Concord Drugs stock has moved up by 12.9%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 45.61% to 54.92% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 6 quarters, 0.04 Cr → 1.11 Cr (in ₹), with an average increase of 45.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 37.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 22.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 37.9 Cr → 20.95 Cr (in ₹), with an average decrease of 44.7% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 54.39% to 45.08% in Jun 2026 quarter

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is one of the most reputable pharmaceutical companies in India that manufactures Finished Pharmaceutical Formulations such as Injectables, Small Volume Parenterals, Dry Powder, Tissue BioAdhesive Tablets, Capsules and Ophthalmic Preparations, and Readytofill Pellets. They specialize in cGMP contract manufacturing and FormulationFillFinish facility providing comprehensive pharmaceutical development and manufacturing services for drug products. Through the use of state-of-the-art technology that ensures the highest level of process integrity and product quality, they strive to provide their customers with an end-to-end solution to their various pharmaceutical product needs. In order to meet the standards set by regulatory bodies, their two manufacturing facilities are designed to comply with the prerequisites of these governing bodies.

Revenue: ₹20.94Cr as on June 2026 (Q1 FY27)
Net Profit: ₹1.11Cr as on June 2026 (Q1 FY27)
Chairperson Name: S Nagi Reddy
OrganisationConcord Drugs Ltd
IndustryPharmaceuticals
CEOS Nagi Reddy
E-voting on sharesClick here to vote

FAQs

What is Concord Drugs share price today?

Concord Drugs share price today stands at ₹79.3 as on at the close of the market. Concord Drugs share today touched a day high of ₹79.85 and a low of ₹76.8.

What is the 52 week high and 52 week low range for Concord Drugs share?

Concord Drugs touched a 52 week high of ₹92.52 and a 52 week low of ₹61. Concord Drugs share price today i.e. is closed at ₹79.3, which is -14.29% down from its 52 week high and 30.00% up from its 52 week low.

What is Concord Drugs's market capitalisation today?

Concord Drugs market capitalisation is ₹104.70 Cr as on .

How to buy Concord Drugs shares?

To buy Concord Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 538965 or Concord Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Concord Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Concord Drugs trading volume today?

Concord Drugs trading volume is 2,598.00 as on . This means that 2,598.00 shares of Concord Drugs were bought and sold on the stock market during today's trading session.